Cargando…

A case of pulmonary pleomorphic carcinoma with preexisting interstitial pneumonia successfully treated with pembrolizumab

Pulmonary pleomorphic carcinoma is often refractory to chemotherapy and follows an aggressive clinical course. Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced lung cancer, and a few cases with pleomorphic carcinoma have been reported to show tumor shrinkage after th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sako, Masahiro, Nokihara, Hiroshi, Kondo, Kensuke, Mitsuhashi, Atsushi, Ozaki, Ryohiko, Yabuki, Yohei, Abe, Akane, Yoneda, Hiroto, Ogino, Hirokazu, Otsuka, Kenji, Uehara, Hisanori, Nishioka, Yasuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720630/ https://www.ncbi.nlm.nih.gov/pubmed/34859591 http://dx.doi.org/10.1111/1759-7714.14243

Ejemplares similares

Efficacy and safety of second‐line chemotherapy for patients with advanced non‐small cell lung cancer complicated by interstitial lung disease
por: Otsuka, Kenji, et al.
Publicado: (2022)

Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
por: Yoneda, Hiroto, et al.
Publicado: (2021)

Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion
por: Nokihara, Hiroshi, et al.
Publicado: (2022)

FoundationOne CDx detected an uncovered variant of epidermal growth factor receptor exon 19 deletion by Oncomine Dx target test in a patient with lung adenocarcinoma
por: Takahashi, Hiroki, et al.
Publicado: (2023)

Immune checkpoint inhibitor-related pneumonitis with atypical radiologic features in a patient with anti-aminoacyl-tRNA synthetase antibody
por: Ichihara, Seiya, et al.
Publicado: (2022)

Radiation therapy induces an abscopal effect and upregulates programmed death‐ligand 1 expression in a patient with non‐small cell lung cancer
por: Morita, Yutaka, et al.
Publicado: (2022)

Programmed death (PD)‐1/PD‐ligand 1 blockade mediates antiangiogenic effects by tumor‐derived CXCL10/11 as a potential predictive biomarker
por: Mitsuhashi, Atsushi, et al.
Publicado: (2021)

A multicenter, open‐label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non‐small cell lung cancer
por: Yabuki, Yohei, et al.
Publicado: (2023)

S‐1 eliminates MDSCs and enhances the efficacy of PD‐1 blockade via regulation of tumor‐derived Bv8 and S100A8 in thoracic tumor
por: Nguyen, Na T., et al.
Publicado: (2022)

Analysis of the chemotactic factors for tumor-infiltrating fibrocytes and their prognostic significances in lung cancer
por: Tobiume, Makoto, et al.
Publicado: (2022)

Multidisciplinary treatment of skeletal muscle metastasis from lung cancer: A case of triceps muscle metastasis of lung squamous cell cancer
por: Haji, Keiko, et al.
Publicado: (2021)

Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
por: Takeuchi, Eiji, et al.
Publicado: (2022)

Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors
por: Takeuchi, Eiji, et al.
Publicado: (2023)

Pulmonary pleomorphic carcinoma with pembrolizumab monotherapy
por: Chang, Hao‐Chun, et al.
Publicado: (2020)

A case of pulmonary pleomorphic carcinoma with malignant phenotypes induced by ZEB1-associated epithelial-mesenchymal transition
por: Kondo, Mayo, et al.
Publicado: (2018)

Development, validation, and comparison of gene analysis methods for detecting EGFR mutation from non-small cell lung cancer patients-derived circulating free DNA
por: Hanibuchi, Masaki, et al.
Publicado: (2019)

Single pembrolizumab treatment causing profound durable response in a patient with pulmonary pleomorphic carcinoma
por: Tokuyasu, Hirokazu, et al.
Publicado: (2019)

Pembrolizumab for Previously Untreated Patients with Advanced Non-small-cell Lung Cancer and Preexisting Interstitial Lung Disease
por: Fujita, Tetsuo, et al.
Publicado: (2020)

The Successful Treatment of Pulmonary Pleomorphic Carcinoma with Pembrolizumab: A Case Report
por: Matsumoto, Yoko, et al.
Publicado: (2017)

Successful treatment of metastatic bladder pleomorphic giant cell carcinoma with pembrolizumab
por: Nezu, Kunihisa, et al.
Publicado: (2021)

Pembrolizumab Therapy Triggering an Exacerbation of Preexisting Autoimmune Disease: A Report of 2 Patient Cases
por: Phadke, Sneha D., et al.
Publicado: (2016)

Multiple Metastasizing Pleomorphic Adenomas of the Lung
por: Nakai, Ayaka, et al.
Publicado: (2017)

Robust response of pulmonary pleomorphic carcinoma to pembrolizumab and sequential radiotherapy: A case report
por: Kim, Tae‐Hun, et al.
Publicado: (2021)

A case of adrenal undifferentiated pleomorphic sarcoma with tertiary lymphoid structures responded to pembrolizumab
por: Kokubun, Hidetoshi, et al.
Publicado: (2023)

Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab
por: Mitsuhashi, Atsushi, et al.
Publicado: (2015)

Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravis
por: Tozuka, Takehiro, et al.
Publicado: (2018)

Good and sustained response to pembrolizumab and pazopanib in advanced undifferentiated pleomorphic sarcoma: a case report
por: Arora, Shalabh, et al.
Publicado: (2020)

Radiation-associated Angiosarcoma Presenting as Massive Pleural Effusion
por: Ogino, Hirokazu, et al.
Publicado: (2021)

An Autopsy Case of Aortic Intimal Sarcoma Initially Diagnosed as Polyarteritis Nodosa
por: Toyoda, Yuko, et al.
Publicado: (2016)

Successful control of intestinal bleeding from metastasis of pulmonary pleomorphic carcinoma with pembrolizumab: A case report
por: Ikushima, Hiroaki, et al.
Publicado: (2022)

Prevention of Pemetrexed-Induced Rash Using Low-Dose Corticosteroids: A Phase II Study
por: Sakurada, Takumi, et al.
Publicado: (2022)

Perfusion MR imaging detection of carcinoma arising from preexisting salivary gland pleomorphic adenoma by computer-assisted analysis of time-signal intensity maps
por: Katayama, Ikuo, et al.
Publicado: (2017)

Case report: Postoperative abdominal recurrence of pulmonary pleomorphic carcinoma showed a dramatic response to S-1 after pembrolizumab
por: Kojima, Yuichi, et al.
Publicado: (2021)

Bone Healing in Adolescents with Bilateral L5 Spondylolysis with and without Preexisting Contralateral Terminal Spondylolysis
por: Eto, Fumihiko, et al.
Publicado: (2021)

Pembrolizumab-induced Eosinophilic Gastrointestinal Disorders
por: Nakamura, Masakatsu, et al.
Publicado: (2021)

Effective combined therapy with ramucirumab for advanced pulmonary pleomorphic carcinoma
por: Nishioka, Naoya, et al.
Publicado: (2018)

A New Quinoline Derivative MS‐209 Reverses Multidrug Resistance and Inhibits Multiorgan Metastases by P‐glycoprotein‐expressing Human Small Cell Lung Cancer Cells
por: Nokihara, Hiroshi, et al.
Publicado: (2001)

Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma
por: Tamura, Yosuke, et al.
Publicado: (2015)

Preregistration of Analyses of Preexisting Data
por: Mertens, Gaëtan, et al.
Publicado: (2019)

Preexisting Conditions That Kill Us
por: Hanna-Attisha, Mona, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1ge1hhmb8pehkvk17035qg96er